Translate page

Generic TKI's

A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. In most cases, generic products become available after the patent protections afforded to a drug's original developer expire. With imatinib patent – a commonly used drug for CML – expiring in many countries over a period from 2013 and 2019 generic versions become available for CML treatment in more and more countries. 

The iCMLf welcomes that generic drugs can help to increase the availability of affordable medicines and to contain health care costs especially in those countries with limited resources like the emerging markets. But the iCMLf also raises concerns over the impact on quality and safety of CML treatment if products are switched for non-medical reason.

Learn more about CML generic TKI'sLogo CML Advocates Network

If you want to learn more about generic drugs for CML we recommend to you the ‘Resource and knowledge Center on CML generics, copy drugs and substandard drugs’ run by the CML Advocates Network.